Chargement en cours...
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
BACKGROUND: Sorafenib can prolong the survival of patients with advanced hepatocellular carcinoma (HCC). However, drug resistance remains the main obstacle to improving its efficiency. This study aimed to explore the likely molecular mechanism of sorafenib resistance. METHODS: Differentially express...
Enregistré dans:
| Publié dans: | Ann Transl Med |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859776/ https://ncbi.nlm.nih.gov/pubmed/33553331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2081 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|